Tel Aviv, Israel

Marcelo Ehrlich

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Marcelo Ehrlich: Innovator in Oncolytic Virus Research

Introduction

Marcelo Ehrlich is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic viruses for cancer treatment. With a total of 3 patents, his work is at the forefront of innovative medical research.

Latest Patents

One of his latest patents is the Epizootic Hemorrhagic Disease virus-Tel Aviv University (EHDV-TAU), which is an oncolytic virus designed for treating cancer. This invention focuses on methods and pharmaceutical compositions that aim to prevent or treat cancer by targeting alterations in interferon signaling and the innate immune antiviral response. Another notable patent involves systems and methods for the detection of cellular stress. This patent outlines methods for measuring stress in a cell by introducing a labeled tRNA and detecting changes in its subcellular localization in real time.

Career Highlights

Ehrlich has worked with notable organizations such as Ramot at Tel Aviv University Ltd. and Anima Cell Metrology. His experience in these companies has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Marcelo has collaborated with esteemed colleagues, including Orna Elroy-Stein and Sima Barhoom. These partnerships have further enriched his research endeavors and innovations.

Conclusion

Marcelo Ehrlich is a distinguished inventor whose work in oncolytic viruses and cellular stress detection is paving the way for advancements in cancer treatment. His contributions to biotechnology are significant and continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…